Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
Open Access
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 265 (28) , 17209-17214
- https://doi.org/10.1016/s0021-9258(17)44890-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The genetic polymorphism of debrisoquine/sparteine metabolism—molecular mechanismsPharmacology & Therapeutics, 1990
- Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in manBiochemistry, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22Genomics, 1988
- Signals for the selection of a splice site in pre-mRNAJournal of Molecular Biology, 1987
- Expression of Bovine 17α-Hydroxylase Cytochrome P-450 cDNA in Nonsteroidogenic (COS 1) CellsScience, 1986
- Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNACell, 1986
- The genetic polymorphism of sparteine metabolismXenobiotica, 1986
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- SV40-transformed simian cells support the replication of early SV40 mutantsCell, 1981